Objective: Sleep problems like obstructive sleep apnea (OSA) are common in polycystic ovary syndrome (PCOS), although the underlying mechanisms are not well understood. We aimed to determine the prevalence of sleep problems, synthesise and appraise studies analysing the associations between serum sex hormones, sex hormone‐binding globulin (SHBG) and sleep problems in females with PCOS.Design: Systematic review and meta‐analysis.Methods: A systematic search using MEDLINE, Embase, PsycInfo, CINAHL, Scopus, and Google Scholar was performed till 3 August 2024. Studies that examined serum sex hormones, SHBG or hyperandrogenism with sleep disorders and/or sleep disturbances in PCOS were eligible. Random effects meta‐analyses of sex hormones and SHBG among females with PCOS with compared to without OSA were conducted.Results: From 4487 screened studies, 24 were included, with nine suitable for meta‐analyses. Among females with PCOS, 46.0% had OSA and 56.0% had other sleep disturbances. SHBG levels were significantly lower in women with PCOS and OSA compared to those without OSA (standardised mean difference = −0.62; 95% CI = −0.82 to −0.42; I2 = 0%; 179 participants; p < 0.00001), but no differences were seen in total and free testosterone, dehydroepiandrosterone sulfate, androstenedione, and oestradiol. No significant associations between serum sex hormones, SHBG or hyperandrogenism with sleep disturbances in PCOS were observed.Conclusion: SHBG, rather than hyperandrogenism, may play a more important mechanistic role for OSA in PCOS, while other sleep disturbances exhibit a less severe SHBG profile. These findings enhance comprehension of underlying pathophysiology of sleep problems in PCOS. Further validation across PCOS populations is warranted.
Background: Maternal chronotype, maternal sleep, and breastfeeding practices are separately associated with maternal mood. However, it is not known if maternal mood mediates the associations between maternal chronotype or maternal sleep and breastfeeding duration. Objective: To investigate whether maternal mood mediates the associations of maternal chronotype and maternal prenatal sleep with breastfeeding duration in a multiethnic cohort of Singaporean mothers. Methods: In a prospective cohort study, caregivers of term-born, singleton infants (N = 340) completed the Horne–Östberg Morningness–Eveningness Questionnaire (MEQ; 54 months), Pittsburgh Sleep Quality Index (PSQI; 26 weeks gestation), Edinburgh Postnatal Depression Scale (EPDS; 26–28 weeks gestation) and State–Trait Anxiety Inventory (STAI-state, STAI-trait; 26–28 weeks gestation) and reported breastfeeding practices from 3 weeks to ≥12 months. Regression and mediation analyses were adjusted for maternal age, parity, maternal education, ethnicity, pre-pregnancy BMI, and mode of delivery. Results: Morningness was significantly associated with a longer breastfeeding duration (β = 0.02, p = 0.037) and lower maternal anxiety symptoms (STAI-state: β = −0.19, p = 0.006 and STAI-trait: β = −0.18, p = 0.004). Lower maternal anxiety symptoms were significantly associated with a longer breastfeeding duration (STAI-state: β = −0.02, p = 0.003; STAI-trait: β = −0.02, p = 0.016). STAI-state, but not STAI-trait or EPDS, mediates the association between maternal chronotype and breastfeeding duration (βindirect = 0.004 (0.0004, 0.009)). Maternal mood did not mediate the association between maternal night sleep duration and breastfeeding duration. Conclusions: Maternal state-anxiety constitutes a behavioral pathway through which maternal chronotype influences breastfeeding duration. Strategies to target maternal anxiety in pregnant women with eveningness tendencies to promote breastfeeding duration are warranted.
25 February 2026 in The Journal of Clinical Endocrinology & Metabolism
Background: Sleep disturbances are common in women with polycystic ovary syndrome (PCOS), but no prospective studies have explored whether childhood–adolescence sleep disturbances are associated with later PCOS risk. Understanding behavioral markers may support early identification and intervention. Objective: To examine whether poor sleep behaviors from childhood to adolescence are prospectively associated with a diagnosis of PCOS at age 14 years. Materials and methods: Sleep behavior data (Child Behavior Checklist) from a longitudinal study of 226 female participants of the Raine Study cohort (37 with PCOS), assessed at ages 5, -8, -10, and -14 years, with PCOS diagnosis at age 14 years were analyzed. PCOS diagnosis was based on both hyperandrogenism and ovulatory dysfunction according to the 2023 PCOS Guideline adolescent diagnostic criteria. Generalized estimating equations examined longitudinal sleep behavior differences by PCOS status at age 14; logistic regression explored specific sleep behavior associations with PCOS risk at age 14. Results: After adjustment for covariates, results showed higher sleep behavior problem scores from childhood to adolescence, with differences becoming more pronounced over time among girls with PCOS at age 14 (adjusted mean difference = 0.49; 95% CI = 0.10-0.87; P = .013). Analysis of individual items showed significant associations between PCOS at age 14 and “trouble sleeping” at age 10 (odds ratio [OR] = 2.95; 95% CI = 1.30-6.69) and “sleeping less than most kids” at age 10 (OR = 2.48; 95% CI = 1.18-5.22). Conclusion: Sleep difficulties may serve as early, modifiable behavioral markers of PCOS risk. Poor sleep may worsen hormonal and metabolic dysfunction, promoting insulin resistance, obesity, and sleep disturbances.